Exchange: NASDAQ·Updated 07:47 AM EDT

About BBOT

About

Bridgebio Oncology Therapeutics, Inc. engages in developing bioavailable small molecule inhibitors. It focuses on advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Ka malignancies. The company was founded on August 1, 2016 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
92

Frequently Asked Questions

What is Market Cap of BridgeBio Oncology Therapeutics Inc.?
What is the 52-week high for BridgeBio Oncology Therapeutics Inc.?
What is the 52-week low for BridgeBio Oncology Therapeutics Inc.?
What is BridgeBio Oncology Therapeutics Inc. stock price today?
What was BridgeBio Oncology Therapeutics Inc. stock price yesterday?
What is the Price-to-Book ratio of BridgeBio Oncology Therapeutics Inc.?
What is the 50-day moving average of BridgeBio Oncology Therapeutics Inc.?
How many employees does BridgeBio Oncology Therapeutics Inc. have?

Advertisement|Remove ads.